This review posits that the PI3K/Akt/mTOR signaling pathway acts as the central integrator of this process, becoming fundamentally rewired—or “imprinted”—by the unique pathological context of IR/MASH-HCC. The gene discussed is AKT1; the disease is hepatocellular carcinoma.